FDA Consent Decree & DOJ Injunction Legal Defense

Navigating Federal Injunctions, Enforcement Defense, and Operational Continuity

Facing an FDA consent decree or DOJ injunction can threaten your company’s operations, financial stability, and future. Our regulatory counsel helps you respond strategically, negotiate workable compliance obligations, and navigate enforcement proceedings while pursuing opportunities to preserve critical business activities and address FDA concerns effectively.

Strategic Defense for Consent Decrees & DOJ Injunctions

Lawyer reviewing legal documents and using a laptop

Over the past 16 years, we have represented companies facing the FDA's most severe enforcement actions, including federal injunctions and Consent Decrees negotiated alongside the Department of Justice (DOJ).

A Consent Decree is not just a legal penalty; it is a strict, court-ordered operational overhaul that can paralyze a business if not negotiated carefully. We work directly with executive teams, technical experts, and federal prosecutors to negotiate the scope of the decree, ensuring that compliance milestones are realistic and that the company can maintain critical operations where possible.

In recent matters, we have guided manufacturers through the rigorous third-party audit requirements mandated by a decree, systematically correcting systemic quality failures to build a defensible track record and eventually petition the FDA to lift the injunction.

Key Provisions and Negotiation Strategies in DOJ Injunctions

check 3 Negotiating Scope and Compliance Timelines: We negotiate proposed decree terms with federal attorneys, seeking realistic deadlines and tailored exceptions. This includes limiting obligations for managing FDA product recalls and preserving unaffected product lines where permitted.

check 3 Shutdown & Cessation Provisions: A decree can require affected production or distribution to stop until specified conditions are satisfied. We evaluate restart requirements, which may include expert certification of cGMP compliance, FDA inspections, and written agency authorization.

check 3 Independent Expert Certification: Decrees may require qualified independent experts to conduct quality audits and submit findings directly to the FDA. We coordinate with these experts to clarify reporting obligations, document corrective actions, and address required compliance milestones.

check 3 Liquidated Damages: Decree provisions may authorize financial assessments for subsequent noncompliance without a new enforcement lawsuit. We review the triggering conditions, calculation methods, and available review procedures to clarify exposure and support ongoing compliance planning.

check 3 Sunset Clauses & Petitioning for Relief: We assess termination provisions and the sustained compliance evidence needed to seek relief. Where appropriate, we pursue defined benchmarks supporting a petition to the federal court to dissolve the decree.

Managing Third-Party Audits and cGMP Remediation

Law legal justice court attorney judge regulation policy

Consent decrees may require independent experts to evaluate manufacturing practices, identify compliance gaps, and report findings directly to FDA. We help clarify audit scope, expert qualifications, and submission deadlines so your team understands its obligations under the court order.

Our counsel works alongside quality assurance consultants to structure corrective and preventive action (CAPA) plans addressing identified deficiencies and decree requirements. Each corrective measure should include documented implementation and verification of effectiveness. Organized audit reports, validation records, and training documentation help demonstrate measurable progress to FDA investigators.

Restarting restricted operations requires satisfying the decree’s conditions and obtaining written FDA authorization when required. We coordinate with the responsible FDA offices, including the Office of Inspections and Investigations, formerly ORA, during reinspection and compliance review. Continued audits, timely reporting, and effective quality controls support sustained compliance and help reduce exposure to liquidated damages.

The Step-by-Step Process to Lifting an Injunction

01
Establish Sustained Compliance

Complete required corrective actions and demonstrate sustained compliance throughout the specified period.

02
Document Independent Verification

Obtain required independent audit certifications documenting effective remediation and continued regulatory compliance.

03
Seek Government Non-Opposition

Coordinate with DOJ and FDA counsel to seek non-opposition before requesting dissolution.

04
Obtain Court-Ordered Relief

Petition the federal court for termination, removing restrictions as its order permits.

Preventing Injunctions Through Early Enforcement Defense

Effective consent decree defense begins before DOJ files a complaint. Responding to FDA Form 483 inspectional observations requires a clear explanation of corrective actions, supporting evidence, and achievable completion dates. Our proactive Warning Letter defense helps businesses address regulatory concerns before enforcement escalates. Legal review strengthens these submissions by ensuring factual accuracy, avoiding unsupported admissions, and aligning commitments with your company’s remediation capabilities.

With more than 16 years of regulatory enforcement experience, FDA Atty helps companies navigate threats to their assets, operations, and commercial future. We work with executives to develop credible responses and prioritize corrective measures that address FDA’s concerns. Our approach supports informed decisions, preserves negotiating opportunities, and helps leadership maintain credibility throughout the enforcement process.

“